Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases.

IF 3.4 2区 医学 Q2 CLINICAL NEUROLOGY
Volkan Demircan
{"title":"Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases.","authors":"Volkan Demircan","doi":"10.1007/s11060-026-05787-x","DOIUrl":null,"url":null,"abstract":"<p><p>The optimal management of brain metastases involving the primary motor cortex requires balancing local tumor control with preservation of neurological function. Kraus et al. provide valuable evidence supporting microsurgical resection (MSR) in appropriately selected patients; however, comparisons between MSR and stereotactic radiotherapy (SRT) warrant careful interpretation. Treatment allocation was influenced by baseline performance status, motor function, disease burden, and lesion characteristics. Patients undergoing surgery had greater baseline motor impairment and therefore greater opportunity for measurable improvement, whereas preservation of intact or near-intact function after SRT may be categorized as stability despite being clinically meaningful. Conversely, 17 of the 41 patients initially allocated to SRT underwent salvage surgery for progression or a new neurological deficit and were excluded from the comparative SRT cohort. This 41% crossover both selects the analysed SRT cohort for patients in whom radiotherapy was successful and identifies a clinically important subgroup with poor outcomes after initial SRT. Furthermore, postoperative radiotherapy was administered to 95% of surgically treated patients with available data, indicating that the study compares a multimodality strategy of MSR followed by postoperative irradiation with definitive SRT rather than isolated surgery with radiotherapy. The unreported extent of resection further complicates interpretation of local control and the contribution of postoperative treatment. Collectively, the findings support surgery for appropriately selected patients, particularly those with large symptomatic lesions requiring rapid decompression, but do not establish better functional outcomes with surgery than with SRT after accounting for treatment selection. Future studies should report outcomes from initial treatment allocation through salvage therapy and evaluate individualized strategies incorporating lesion volume, baseline neurological status, corticospinal tract involvement, extent of resection, systemic disease burden, and the need for immediate decompression.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":"179 2","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-026-05787-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The optimal management of brain metastases involving the primary motor cortex requires balancing local tumor control with preservation of neurological function. Kraus et al. provide valuable evidence supporting microsurgical resection (MSR) in appropriately selected patients; however, comparisons between MSR and stereotactic radiotherapy (SRT) warrant careful interpretation. Treatment allocation was influenced by baseline performance status, motor function, disease burden, and lesion characteristics. Patients undergoing surgery had greater baseline motor impairment and therefore greater opportunity for measurable improvement, whereas preservation of intact or near-intact function after SRT may be categorized as stability despite being clinically meaningful. Conversely, 17 of the 41 patients initially allocated to SRT underwent salvage surgery for progression or a new neurological deficit and were excluded from the comparative SRT cohort. This 41% crossover both selects the analysed SRT cohort for patients in whom radiotherapy was successful and identifies a clinically important subgroup with poor outcomes after initial SRT. Furthermore, postoperative radiotherapy was administered to 95% of surgically treated patients with available data, indicating that the study compares a multimodality strategy of MSR followed by postoperative irradiation with definitive SRT rather than isolated surgery with radiotherapy. The unreported extent of resection further complicates interpretation of local control and the contribution of postoperative treatment. Collectively, the findings support surgery for appropriately selected patients, particularly those with large symptomatic lesions requiring rapid decompression, but do not establish better functional outcomes with surgery than with SRT after accounting for treatment selection. Future studies should report outcomes from initial treatment allocation through salvage therapy and evaluate individualized strategies incorporating lesion volume, baseline neurological status, corticospinal tract involvement, extent of resection, systemic disease burden, and the need for immediate decompression.

治疗选择还是治疗效果?解释运动皮质转移的功能结果。
涉及初级运动皮层的脑转移的最佳管理需要平衡局部肿瘤控制与神经功能的保存。Kraus等人提供了有价值的证据,支持在适当选择的患者中进行显微外科切除(MSR);然而,MSR和立体定向放疗(SRT)之间的比较需要仔细解释。治疗分配受基线运动状态、运动功能、疾病负担和病变特征的影响。接受手术的患者有更大的基线运动损伤,因此有更大的机会得到可测量的改善,而在SRT后保留完整或接近完整的功能可能被归类为稳定,尽管具有临床意义。相反,最初分配到SRT的41例患者中有17例因进展或新的神经功能缺陷而进行了补救性手术,并被排除在比较SRT队列之外。这41%的交叉既选择了放射治疗成功的患者分析的SRT队列,也确定了初始SRT后预后较差的临床重要亚组。此外,根据现有数据,95%的手术治疗患者接受了术后放疗,这表明该研究比较了MSR后术后放疗与明确SRT的多模式策略,而不是孤立手术与放疗。未报道的切除范围进一步使局部控制的解释和术后治疗的贡献复杂化。总的来说,研究结果支持对适当选择的患者进行手术,特别是那些有较大症状的病变需要快速减压的患者,但在考虑治疗选择后,手术的功能结果并没有比SRT更好。未来的研究应报告通过挽救性治疗的初始治疗分配的结果,并评估个体化策略,包括病变体积、基线神经状态、皮质脊髓束受累程度、切除程度、全身性疾病负担和立即减压的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书